P.2.016 Exposure to an alternative reward does not reduce cocaine-seeking behaviour
Autor: | C. Lafay-Chabassier, M. Solinas, C. Nicolas |
---|---|
Rok vydání: | 2013 |
Předmět: |
Pharmacology
medicine.medical_specialty business.industry Methylphenidate medicine.medical_treatment media_common.quotation_subject Rat model Atomoxetine Noradrenaline reuptake inhibitor Impulsivity Stimulant Psychiatry and Mental health Endocrinology Neurology Internal medicine medicine Pharmacology (medical) Neurology (clinical) medicine.symptom business Biological Psychiatry medicine.drug Cocaine seeking Vigilance (psychology) media_common |
Zdroj: | European Neuropsychopharmacology. 23:S39-S40 |
ISSN: | 0924-977X |
DOI: | 10.1016/s0924-977x(13)70044-0 |
Popis: | on attention, impulsivity and performance in adult rats separated into high and low-performers in the 5C-CPT. The effects of acute methylphenidate (MPH) 0.5, 1.0, and 2.0mg/kg i.p, and atomoxetine (ATMX) 0.2, 1.0, 2.0mg/kg i.p were assessed in the 5C-CPT in female Lister-hooded rats (n = 40). Animals were trained for 60 sessions and then divided into two groups (high and low performers) based on set criteria. Animals were challenged on test days by increasing the inter-trial interval (ITI) from 5s to 10s. ATMX significantly reduced premature responding in low performers at 1.0 and 2.0mg/kg (p< 0.05). ATMX (2.0mg/kg) significantly increased % accuracy and reduced false alarm rate (p< 0.05) in poor performers. ATMX (1.0mg/kg, 2.0mg/kg) significantly increased sensitivity index in low performers (p< 0.05; p< 0.01), and significantly decreased responsivity index (p< 0.05) MPH at 2.0mg/kg significantly improved accuracy (p< 0.05), and reduced premature responding (p< 0.05) in low performers and increased premature responding in high performers (p< 0.05). MPH significantly increased correct rejections in high performers at 2.0mg/kg (p< 0.05), and decreased correct rejections at all doses in low performers (p< 0.01, p< 0.05, p< 0.05 respectively). MPH significantly increased sensitivity index in low performers at 0.5 and 1.0mg/kg (p< 0.01). In summary, ATMX (noradrenaline reuptake inhibitor, non-stimulant) reduced impulsivity in low performers in both the 5-CSRTT (premature responses) and in the 5C-CPT (false alarm rate). ATMX enhanced sustained attention in the 5CSRTT and vigilance in 5C-CPT in low performers. Methylphenidate (dopamine/noradrenaline reuptake inhibitor, psychostimulant) enhanced sustained attention in the 5-CSRTT, vigilance in the 5C-CPT (% correct rejections) and marginally reduced impulsivity in low performers in the 5C-CPT. This would suggest that low performers are more sensitive to the effects of both stimulant and non-stimulant drugs. These data provide the validation of a rat model for the inattentive subtype of adult ADHD. The model utilises the 5C-CPT to select for those with deficits in sustained attention and vigilance, which can then be enhanced by ADHD medication. |
Databáze: | OpenAIRE |
Externí odkaz: |